RYTM · Company research
Rhythm Pharmaceuticals, Inc. (RYTM): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
16records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| JPMorgan reports 3.56 million shares in Rhythm Pharmaceuticals (RYTM), exceeding the 5% threshold. - Stock Titan | JPMorgan reports 3.56 million shares in Rhythm Pharmaceuticals (RYTM), exceeding the 5% threshold. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| Rhythm Pharmaceuticals (RYTM) Upgraded to Buy: Here's What You Should Know | Rhythm Pharmaceuticals has been upgraded to a Zacks Rank #2 (Buy) rating, reflecting upward trends in earnings estimates over the past three months (up 8.5%). The upgrade positions the stock in the top 20% of Zacks-covered stocks, suggesting potential for near-term price appreciation driven by improving business fundamentals and institutional investor buying pressure. | View source ↗ | Zacks Investment Research | Oct 13, 2026 | bullish | 1 | 1 |
| How Investors May Respond To Rhythm Pharmaceuticals (RYTM) Progress In Prader-Willi And Genetically Defined Obesity Therapies - Yahoo Finance | How Investors May Respond To Rhythm Pharmaceuticals (RYTM) Progress In Prader-Willi And Genetically Defined Obesity Therapies Yahoo Finance | View source ↗ | Yahoo Finance | Oct 13, 2026 | neutral | 0 | 0.6 |
| Rhythm Pharmaceuticals (NasdaqGM:RYTM) Stock Forecast & Analyst Predictions - Simply Wall Street | Rhythm Pharmaceuticals (NasdaqGM:RYTM) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Oct 9, 2026 | neutral | 0 | 0.6 |
| Here’s How Much You Would Have Made Owning Rhythm Pharmaceuticals Stock In The Last 5 Years - Benzinga | Here’s How Much You Would Have Made Owning Rhythm Pharmaceuticals Stock In The Last 5 Years Benzinga | View source ↗ | Benzinga | Oct 8, 2026 | neutral | 0 | 0.6 |
| Canada approves first targeted treatment for obesity caused by brain injury - Stock Titan | Canada approves first targeted treatment for obesity caused by brain injury Stock Titan | View source ↗ | Stock Titan | Sep 22, 2026 | neutral | 0 | 0.6 |
| Rhythm Pharmaceuticals (RYTM) Stock Looks Overvalued Despite Its 7x Five Year Run - Yahoo Finance | Rhythm Pharmaceuticals (RYTM) Stock Looks Overvalued Despite Its 7x Five Year Run Yahoo Finance | View source ↗ | Yahoo Finance | Aug 26, 2026 | neutral | 0 | 0.6 |
| Rhythm Pharmaceuticals (RYTM) Stock Looks Pricey Following Strong IMCIVREE News - Simply Wall St | Rhythm Pharmaceuticals (RYTM) Stock Looks Pricey Following Strong IMCIVREE News Simply Wall St | View source ↗ | Simply Wall St | Aug 17, 2026 | neutral | 0 | 0.6 |
| Rhythm Pharmaceuticals(RYTM.US) Officer Sells US$8.9 Million in Common Stock - Moomoo | Rhythm Pharmaceuticals(RYTM.US) Officer Sells US$8.9 Million in Common Stock Moomoo | View source ↗ | Moomoo | Aug 14, 2026 | neutral | 0 | 0.6 |
| Could Anticipated Q2 Earnings Beat Amid Weaker Profitability Reframe Rhythm Pharmaceuticals’ Growth Story (RYTM)? - Yahoo Finance | Could Anticipated Q2 Earnings Beat Amid Weaker Profitability Reframe Rhythm Pharmaceuticals’ Growth Story (RYTM)? Yahoo Finance | View source ↗ | Yahoo Finance | Jul 28, 2026 | neutral | 0 | 0.6 |
| Is Rhythm Pharmaceuticals, Inc. (RYTM) Stock Poised for Growth After Encouraging Setmelanotide Trial Results? - Yahoo Finance | Is Rhythm Pharmaceuticals, Inc. (RYTM) Stock Poised for Growth After Encouraging Setmelanotide Trial Results? Yahoo Finance | View source ↗ | Yahoo Finance | Jun 30, 2026 | neutral | 0 | 0.6 |
| Rhythm Pharmaceuticals Stock Surges 28%, With A 12-Day Winning Spree - Trefis | Rhythm Pharmaceuticals Stock Surges 28%, With A 12-Day Winning Spree Trefis | View source ↗ | Trefis | Jun 30, 2026 | neutral | 0 | 0.6 |
| Rhythm Pharmaceuticals Stock Rockets 28% With 11-Day Winning Streak - Trefis | Rhythm Pharmaceuticals Stock Rockets 28% With 11-Day Winning Streak Trefis | View source ↗ | Trefis | Jun 29, 2026 | neutral | 0 | 0.6 |
| RYTM Forecast — Price Target — Prediction for 2027 - TradingView | RYTM Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| 8-Day Rally Sends Rhythm Pharmaceuticals Stock Up 24% - Trefis | 8-Day Rally Sends Rhythm Pharmaceuticals Stock Up 24% Trefis | View source ↗ | Trefis | Jun 24, 2026 | neutral | 0 | 0.6 |
| RYTM Stock Climbs As PWS Data Drive Analyst Upgrades - StocksToTrade | RYTM Stock Climbs As PWS Data Drive Analyst Upgrades StocksToTrade | View source ↗ | StocksToTrade | Jun 17, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.